ACADIA Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference (Virtual) Transcript
RBC Global Healthcare Conference. My name is Greg Renza, one of the senior biotechnology equity research analysts here at RBC, and we're pleased to have ACADIA Pharmaceuticals with us today. And joining us from the team is Steve Davis, Chief Executive Officer; Serge Stankovic, President; and Elena Ridloff, the VP and Chief Financial Officer.
And just some housekeeping before we do get started. If you do have any questions for the team, please feel free to enter those in the web portal below, and we would be happy to ask those on your behalf.
So let's get started. Steve, over to you. Thank you for joining us. And perhaps we can just start by allowing you to provide an overview of ACADIA.
Yes. Great. Thanks much, Greg. Look forward to just doing a little bit of a quick level setting here, and then we'll get right to the Q&A.
So I'd like to just start by highlighting the 3 strategic pillars of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
